ClinicalTrials.gg
Not yet recruitingNCT06758310Updated Sep 25, 2025

Exercise Effects in Native American Adolscents

An interventional study of Individualized Exercise in Fitness Testing, sponsored by Midwestern University. Not yet recruiting. Open to participants aged 11 Years to 17 Years, including healthy volunteers. Per ClinicalTrials.gov, last updated 2025-09-25.

Sponsored by Midwestern University · Not applicable, Interventional, and Treatment

From the registry’s dates

  • Primary completion was expected by Dec 2025, 10 months ago, but the record still lists the study as not yet recruiting.
Phase
Not applicable
Study type
Interventional
Enrollment
10
Allocation
Not applicable
Ages
11 Years to 17 Years
Sex
All
01

Study summary

This longitudinal study will investigate effects of exercise participation in Southwest Native American adolescents, ages 11-17, from the Gila River Indian Community. Vital signs, physical activity participation adherence, physical performance measures, and psychological/social measures will be assessed. Participants will attend one educational presentation for the initial session, explaining the benefits of physical exercise and expectations throughout the program. Baseline measurements for strength, flexibility, and cardiovascular fitness will be taken as well as height, weight and blood pressure. Based on individual performance measures, each participant will be provided a personalized exercise program to complete 3-4 times/week for the duration for the duration of the study. Participants will also be provided an exercise journal to track their adherence to their exercise program each week. At the end of the session parents and adolescents separately will be asked to complete a written survey assessing physical, emotional, social, and school function. Physical performance measures will be taken every other week from the initial education and data collection session through 6 weeks.

02

Conditions studied

  • Fitness Testing
03

In context

Lead sponsor

Midwestern University is the lead sponsor of 20 studies on the registry; 5 are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
11 Years to 17 Years
Sexes eligible
All
Accepts healthy volunteers
Yes

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  • Active members of the Gila River Indian Community (GRIC) with Native American ancestry
  • Ages 11-17

Exclusion criteria

Exclusion Criteria:

  • Not active members of the GRIC or no Native American ancestry
  • Age \<11 or >17
05

Study design

Phase
Not applicable
Primary purpose
Treatment
Allocation
Not applicable
Intervention model
Single group
Masking
None (open label)
Enrollment
10 participants (estimated)

Study arms

  • Experimental
    Individualized exercise

    Other: Individualized Exercise

Interventions

  • OtherIndividualized Exercise

    Each participant will be prescribed an individualized exercise program related to their fitness testing results and personal interests.

06

What researchers measure

Primary outcomes

  1. Push ups

    Performed in 1 min

    Time frame: 6 weeks

  2. Sit ups

    Performed in 1 min

    Time frame: 6 weeks

  3. Sit and Reach

    Flexibility assessment

    Time frame: 6 weeks

  4. 1 mile run

    For time

    Time frame: 6 weeks

  5. Resting Heart Rate

    Time frame: 6 weeks

Secondary outcomes

  1. Blood Pressure

    Time frame: 6 weeks

07

Study locations

No study locations are listed for this record.

08

References and documents

Individual participant data

Plan to share: No

No publications or documents are linked to this record.

09

Timeline

Tracking since Sep 25, 2026
ElapsedEstimatedEstimated, not yet reached

Start is estimated for Nov 2025; primary completion for Dec 2025, 1 month later.

How these figures are worked out, and which studies are left out of them.

Registered
Dec 26, 2024
First posted
Jan 3, 2025
StartEst.
Nov 16, 2025
Primary completionEst.
Dec 20, 2025
CompletionEst.
Dec 20, 2025
Last update
Sep 25, 2025
What these dates mean
Start.
When the first participant enrolled; while estimated, when the study expects to open to recruitment.
Primary completion.
When the last participant was examined or treated to collect data for the study's main question, its primary outcome. A study that stopped early gives the date its data collection stopped.
Completion.
When the last participant's last visit took place, for every outcome, secondary ones and side effects included: the end of the study. Often later than primary completion, sometimes the same day.
Actual and Est.
Actual means the registry says the date has happened. Est. (estimated) is a date the sponsor plans or expects. It can still move, and the sponsor is expected to change it to actual once it has passed.
No changes since tracking began. The registry record was last updated on Sep 25, 2025, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT06758310
Lead sponsor
Midwestern University
Responsible party
Joshua Subialka (Assistant Professor, Midwestern University) — Principal investigator
First posted
Jan 3, 2025
Start date
Nov 16, 2025 (estimated)
Primary completion
Dec 20, 2025 (estimated)
Completion
Dec 20, 2025 (estimated)
Last update
Sep 25, 2025

Study contacts

Josh Subialka, DPT, DSc
Contact
jsubia@midwestern.edu
763-228-6370

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is not yet recruiting, as verified in Sep 2025. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion